Covered recipient · General Payments record
RONALD D WINTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$2,364.05
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.14 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $134.66 | 9 |
| ABBVIE INC. | $70.46 | 3 |
| DEXCOM, INC. | $44.64 | 2 |
| Novo Nordisk AS | $37.97 | 2 |
| Acerta Pharma LLC | $27.36 | 2 |
| PFIZER INC. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.75 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108428624 | CMS |
| ABBVIE INC. | $21.05 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108428626 | CMS |
| ABBVIE INC. | $26.66 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108428628 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.18 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105341899 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.18 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104404053 | CMS |
| Dexcom, Inc. | $16.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384176 | CMS |
| Dexcom, Inc. | $28.28 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384178 | CMS |
| Lilly USA, LLC | $12.47 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135954479 | CMS |
| Lilly USA, LLC | $20.33 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135932922 | CMS |
| Lilly USA, LLC | $13.57 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135937904 | CMS |
| Lilly USA, LLC | $12.23 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135924390 | CMS |
| Lilly USA, LLC | $16.82 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933296 | CMS |
| Lilly USA, LLC | $21.83 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135901338 | CMS |
| Lilly USA, LLC | $11.62 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135937906 | CMS |
| Lilly USA, LLC | $12.30 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135882805 | CMS |
| Lilly USA, LLC | $13.49 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135859243 | CMS |
| Novo Nordisk Inc | $20.62 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100262882 | CMS |
| Novo Nordisk Inc | $17.35 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100336675 | CMS |
| PFIZER INC. | $14.05 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131533577 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.